 |
9-cis-retinoic acid |
|---|---|
| Trade Name | |
| Orphan Indication | Prevention of retinal detachment due to proliferative vitreoretinopathy |
| USA Market Approval | USA |
| USA Designation Date | 1997-01-02 00:00:00 |
| Sponsor | Allergan, Inc.;2525 Dupont Drive, P.O. Box 19534;Irvine, California, 92623 |
